|
Name |
Pestalone
|
Molecular Formula | C21H20Cl2O6 | |
IUPAC Name* |
2-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylbenzoyl)-4,6-dihydroxy-3-(3-methylbut-2-enyl)benzaldehyde
|
|
SMILES |
CC1=C(C(=C(C(=C1Cl)OC)C(=O)C2=C(C(=CC(=C2C=O)O)O)CC=C(C)C)O)Cl
|
|
InChI |
InChI=1S/C21H20Cl2O6/c1-9(2)5-6-11-13(25)7-14(26)12(8-24)15(11)19(27)16-20(28)17(22)10(3)18(23)21(16)29-4/h5,7-8,25-26,28H,6H2,1-4H3
|
|
InChIKey |
ACRANQNXYMAQKJ-UHFFFAOYSA-N
|
|
Synonyms |
Pestalone; Pestalon; CHEMBL489144; 2-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylbenzoyl)-4,6-dihydroxy-3-(3-methylbut-2-enyl)benzaldehyde
|
|
CAS | NA | |
PubChem CID | 10071878 | |
ChEMBL ID | CHEMBL489144 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 439.3 | ALogp: | 6.3 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 104.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 29 | QED Weighted: | 0.319 |
Caco-2 Permeability: | -5.02 | MDCK Permeability: | 0.00001690 |
Pgp-inhibitor: | 0.014 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.043 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.011 | Plasma Protein Binding (PPB): | 101.64% |
Volume Distribution (VD): | 0.187 | Fu: | 0.85% |
CYP1A2-inhibitor: | 0.783 | CYP1A2-substrate: | 0.851 |
CYP2C19-inhibitor: | 0.239 | CYP2C19-substrate: | 0.124 |
CYP2C9-inhibitor: | 0.899 | CYP2C9-substrate: | 0.899 |
CYP2D6-inhibitor: | 0.486 | CYP2D6-substrate: | 0.205 |
CYP3A4-inhibitor: | 0.228 | CYP3A4-substrate: | 0.178 |
Clearance (CL): | 5.124 | Half-life (T1/2): | 0.095 |
hERG Blockers: | 0.018 | Human Hepatotoxicity (H-HT): | 0.287 |
Drug-inuced Liver Injury (DILI): | 0.94 | AMES Toxicity: | 0.498 |
Rat Oral Acute Toxicity: | 0.111 | Maximum Recommended Daily Dose: | 0.941 |
Skin Sensitization: | 0.573 | Carcinogencity: | 0.683 |
Eye Corrosion: | 0.006 | Eye Irritation: | 0.946 |
Respiratory Toxicity: | 0.358 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004842 | 0.817 | D0WY9N | 0.291 | ||||
ENC004838 | 0.761 | D0Q0PR | 0.266 | ||||
ENC004238 | 0.744 | D04FBR | 0.244 | ||||
ENC004233 | 0.690 | D07MEH | 0.236 | ||||
ENC004843 | 0.593 | D0ZX2G | 0.236 | ||||
ENC004839 | 0.541 | D06GCK | 0.229 | ||||
ENC004841 | 0.526 | D05QDC | 0.228 | ||||
ENC002644 | 0.510 | D0WN0U | 0.222 | ||||
ENC001395 | 0.455 | D0B1IP | 0.217 | ||||
ENC000921 | 0.447 | D06JGH | 0.216 |